Dawn Lyle

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Journal: Health technology assessment (Winchester, England)

Published: June 29, 2026

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Journal: Lancet (London, England)

Published: March 23, 2025

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Journal: BMJ open

Published: September 16, 2024

Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial.

Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial.

Journal: The Lancet. Neurology

Published: May 17, 2024

Brain reserve and physical disability in secondary progressive multiple sclerosis.

Brain reserve and physical disability in secondary progressive multiple sclerosis.

Journal: BMJ neurology open

Published: February 05, 2024

Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease.

Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease.

Journal: Journal of neurology

Published: September 27, 2023

Perceptions of digital technology use for monitoring health in people living with neurological disorders.

Perceptions of digital technology use for monitoring health in people living with neurological disorders.

Journal: Journal of the neurological sciences

Published: September 07, 2023

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.

Journal: Brain communications

Published: January 27, 2021

Screening for cognitive impairment among patients with neuromyelitis optica using touchscreen cognitive testing in routine clinical care.

Screening for cognitive impairment among patients with neuromyelitis optica using touchscreen cognitive testing in routine clinical care.

Journal: Journal of neurology

Published: April 05, 2019

Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care.

Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care.

Journal: Frontiers in neurology

Published: February 22, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026